Safety of Polysorbate 80 in the Oncology Setting

Developments of Polysorbate (Tween) based microemulsions: Preclinical drug delivery, toxicity and antimicrobial applications

(2017) Gurpreet Kaur et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: results of a randomized, double-blind phase III trial

(2015) C. Weinstein et al.   ANNALS OF ONCOLOGY

Key interactions of surfactants in therapeutic protein formulations: A review

(2015) Tarik A. Khan et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Docetaxel-loaded nanoparticles of dendrimer-like amphiphilic copolymer for cancer therapy

(2015) Xiaowei Zeng et al.   JOURNAL OF CONTROLLED RELEASE

Aprepitant and Fosaprepitant: A 10-Year Review of Efficacy and Safety

(2015) M. Aapro et al.   ONCOLOGIST

Tween-80 and impurity induce anaphylactoid reaction in zebrafish

(2014) Rui Yang et al.   JOURNAL OF APPLIED TOXICOLOGY

Incidence of infusion-site reactions associated with peripheral intravenous administration of fosaprepitant

(2014) Jordan D. Lundberg et al.   SUPPORTIVE CARE IN CANCER

Fosaprepitant-induced phlebitis: a focus on patients receiving doxorubicin/cyclophosphamide therapy

(2014) A. D. Leal et al.   SUPPORTIVE CARE IN CANCER

An analysis of fosaprepitant-induced venous toxicity in patients receiving highly emetogenic chemotherapy

(2014) Livia T. Hegerova et al.   SUPPORTIVE CARE IN CANCER

Highly Frequent and Enhanced Injection Site Reaction Induced by Peripheral Venous Injection of Fosaprepitant in Anthracycline-Treated Patients

(2014) Yumiko Sato et al.   Journal of Cancer

Therapeutic Efficacy of a Novel Nanosomal Docetaxel Lipid Suspension Compared With Taxotere in Locally Advanced or Metastatic Breast Cancer Patients

(2013) Ateeq Ahmad et al.   Clinical Breast Cancer

Taxanes: Old drugs, new oral formulations

(2013) Rajni A. Jibodh et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Molecular mechanisms of 5-HT3 and NK1 receptor antagonists in prevention of emesis

(2013) Camilo Rojas et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Hypothesis: Increased consumption of emulsifiers as an explanation for the rising incidence of Crohn's disease

(2013) Carol L. Roberts et al.   Journal of Crohns & Colitis

Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial

(2012) H. Saito et al.   ANNALS OF ONCOLOGY

Complement activation by polyethoxylated pharmaceutical surfactants: Cremophor-EL, Tween-80 and Tween-20

(2011) Zsóka Weiszhár et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Single-Dose Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated With Cisplatin Therapy: Randomized, Double-Blind Study Protocol—EASE

(2011) Steven Grunberg et al.   JOURNAL OF CLINICAL ONCOLOGY

Hypersensitivity reactions to anticancer agents: Data mining of the public version of the FDA adverse event reporting system, AERS

(2011) Kaori Kadoyama et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer

(2010) J. D. Rizzo et al.   BLOOD

PM101: intravenous amiodarone formulation changes can improve medication safety

(2010) Paul F Souney et al.   Expert Opinion On Drug Safety

Microtubule-binding agents: a dynamic field of cancer therapeutics

(2010) Charles Dumontet et al.   NATURE REVIEWS DRUG DISCOVERY

Aprepitant

(2009) Monique P. Curran et al.   DRUGS

Polysorbates 20 and 80 Used in the Formulation of Protein Biotherapeutics: Structure and Degradation Pathways

(2007) Bruce A. Kerwin   JOURNAL OF PHARMACEUTICAL SCIENCES